News

B&Q can today reveal it will be the main bricks and mortar stockist of Catherine’s Rose, when it launches in late September.
Roche's Itovebi was the first PI3K inhibitor to get approved as a first-line treatment for breast cancer last year – and new ...
This comes after Kate, 43, had cancer treatment at The Royal Marsden Hospital in London and became a joint patron of The Royal Marsden NHS Foundation Trust Kate Middleton is blooming! On Friday, May 9 ...
Prince William and wife Kate Middleton were able to let loose during their ongoing trip to Scotland. While in the area to ...
CHICAGO -- Adding the PI3K-pathway inhibitor inavolisib (Itovebi) to palbociclib (Ibrance) and fulvestrant significantly ...
King Charles has delayed granting Prince William and Princess Kate the authority to issue royal warrants – a centuries-old tradition that gives selected brands the official royal seal of approval.
STOCKHOLM, May 2, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) is proud to announce that The Royal Marsden NHS Foundation Trust in the UK has treated its first patient using a new and ...
King Charles and Queen Camilla were joined by the likes of David Beckham and Cate Blanchett at the annual gardening event in ...
For every plant sold, £5 will be donated to The Royal Marsden Cancer Charity. Catherine’s Rose aims to raise awareness of the role that spending time outdoors plays in supporting people’s ...
INAVO120 trial shows inavolisib, palbociclib, and fulvestrant significantly improved overall survival in PIK3CA-mutant ...
A combination of two drugs could improve outcomes and reduce the need for toxic chemotherapy for B-cell acute lymphoblastic ...
The RHS honored Princess Catherine with a coral pink rose, with proceeds going to a cause that's close to the Royal Family's heart ...